ADMA Biologics
ADMA
ADMA
188 hedge funds and large institutions have $613M invested in ADMA Biologics in 2023 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 88 increasing their positions, 46 reducing their positions, and 15 closing their positions.
Holders
188
Holders Change
+9
Holders Change %
+5.03%
% of All Funds
3%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
25
Increased
88
Reduced
46
Closed
15
Calls
$402K
Puts
$159K
Net Calls
+$243K
Net Calls Change
-$1.16M
Top Buyers
| 1 |
1
Nuveen Asset Management
Chicago,
Illinois
|
$38.3M |
| 2 |
2
Dimensional Fund Advisors
Austin,
Texas
|
$10.5M |
| 3 |
3
Morgan Stanley
New York
|
$18.8M |
| 4 |
4
Millennium Management
New York
|
$14.7M |
| 5 |
5
Goldman Sachs
New York
|
$8.05M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
IPW
201
Impact Partnership Wealth
Marietta,
Georgia
| – | – | -424 | Closed |
|
|
CAS
202
Coppell Advisory Solutions
Coppell,
Texas
| – | – | -365 | Closed |
|
|
NC
203
NewSquare Capital
Newtown Square,
Pennsylvania
| – | – | -200 | Closed |
|
|
LC
204
Lindbrook Capital
Calabasas,
California
| – | – | – | – |
|
205
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
CFGS
206
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
207
Nomura Asset Management
Tokyo,
Japan
| – | – | – | – |
|